Published in:
Open Access
27-02-2023 | NSCLC | Correction
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
Authors:
E. Pons-Tostivint, P. Hulo, V. Guardiolle, L. Bodot, A. Rabeau, M. Porte, S. Hiret, P. Demontrond, H. Curcio, A. Boudoussier, R. Veillon, M. Mayenga, C. Dumenil, T. Chatellier, P. A. Gourraud, J. Mazieres, J. Bennouna
Published in:
Cancer Immunology, Immunotherapy
|
Issue 6/2023
Login to get access
Excerpt
Correction to: Cancer Immunology, Immunotherapy
https://doi.org/10.1007/s00262-022-03359-2 …